Management of Tuberculosis Infection An Evidence-Based Approach
Tuberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis the bacteria usually attack the lungs due to inhaling bacteria-carrying air droplets but they can also damage other parts of the body by development of this bacteria in the lung from primary (latent TB) to secondary (active TB) to miliary (systemic infection) this development only will occur when the person has weak immune system (those with HIV/AIDS, those receiving chemotherapy, or children under 5 years old for example). (1) In other people who are healthy and with good immune systems at the time of they are infected with latent TB ,active TB disease may not develop until months or years later.(1)
Other
Tuberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis, which is transmission from infected person to another and develop within they’re body if not diagnostic and treated early. Although, the treatment is available TB drug-resistant occurs when bacteria that cause TB develop resistance to the antimicrobial drugs. Moreover, TB is one of the top 10 deadliest diseases in lots of countries especially U.S. The Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) developed a strategy to elimination the TB in early 20th century by the early diagnostic with a several tests and TB drugs treatment with Directly observed treatment (DOT) method a strategy adopted by the World Health Assembly. In May 2014 DOT strategy led to a reduction in the number TB infected people, until the number of TB patients slightly increased again in 2015. The hold on in this strategy has decreased the number again. The global health organizations targets to reduce TB deaths by 90% and to cut new cases by 80% between 2015 and 2030 it’s important to make those strategies one of the Annual TB testing and treatment globally not only in the most affected country to eliminate it completely.
